-
2
-
-
84879619987
-
-
11th edn (eds Schiff, E. R., Maddrey, W. C. & Sorrell, M. F.) Wiley-Blackwell
-
Wong, F. in Schiff's Diseases of the Liver 11th edn (eds Schiff, E. R., Maddrey, W. C. & Sorrell, M. F.) 354-371 (Wiley-Blackwell, 2011).
-
(2011)
Schiff's Diseases of the Liver
, pp. 354-371
-
-
Wong, F.1
-
3
-
-
0023749667
-
Peripheral arterial vasodilatation hypo thesis a proposal for the initiation of renal sodium and water retention in cirrhosis
-
Schrier, R. et al. Peripheral arterial vasodilatation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 8, 1151-1157 (1988).
-
(1988)
Hepatology
, vol.8
, pp. 1151-1157
-
-
Schrier, R.1
-
4
-
-
34548120893
-
Diagnosis prevention and treatment of hepatorenal syndrome in cirrhosis
-
Salerno, F., Gerbes, A., Ginès, P., Wong, F. & Arroyo, V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56, 1310-1318 (2007).
-
(2007)
Gut
, vol.56
, pp. 1310-1318
-
-
Salerno, F.1
Gerbes, A.2
Ginès, P.3
Wong, F.4
Arroyo, V.5
-
5
-
-
77953806441
-
Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites
-
Montoliu, S. et al. Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. Clin. Gastroenterol. Hepatol. 8, 616-622 (2010).
-
(2010)
Clin. Gastroenterol. Hepatol.
, vol.8
, pp. 616-622
-
-
Montoliu, S.1
-
6
-
-
0344256499
-
Hepatorenal syndrome
-
Ginès, P., Guevara, M., Arroyo, V. & Rodés, J. Hepatorenal syndrome. Lancet 362, 1819-1827 (2003).
-
(2003)
Lancet
, vol.362
, pp. 1819-1827
-
-
Ginès, P.1
Guevara, M.2
Arroyo, V.3
Rodés, J.4
-
7
-
-
0032551891
-
Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis
-
Martin, P. Y., Ginès, P. & Schrier, R. W. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N. Engl. J. Med. 339, 533-541 (1998).
-
(1998)
N. Engl. J. Med.
, vol.339
, pp. 533-541
-
-
Martin, P.Y.1
Ginès, P.2
Schrier, R.W.3
-
8
-
-
64749090789
-
Carbon monoxide produced by intrasinusoidally located haem oxygenase 1 regulates the vascular tone in cirrhotic rat liver
-
Van Landeghem, L. et al. Carbon monoxide produced by intrasinusoidally located haem oxygenase 1 regulates the vascular tone in cirrhotic rat liver. Liver Int. 29, 650-660 (2009).
-
(2009)
Liver Int.
, vol.29
, pp. 650-660
-
-
Van Landeghem, L.1
-
9
-
-
0036142225
-
Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat
-
Ros, J. et al. Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 122, 85-93 (2002).
-
(2002)
Gastroenterology
, vol.122
, pp. 85-93
-
-
Ros, J.1
-
10
-
-
0034928628
-
Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis
-
Bátkai, S. et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat. Med. 7, 827-832 (2001).
-
(2001)
Nat. Med.
, vol.7
, pp. 827-832
-
-
Bátkai, S.1
-
11
-
-
0028138887
-
Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis
-
Castro, A. et al. Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis. J. Hepatol. 21, 521-526 (1994).
-
(1994)
J. Hepatol.
, vol.21
, pp. 521-526
-
-
Castro, A.1
-
12
-
-
85027934056
-
Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis
-
Møller, S., Hobolth, L., Winkler, C., Bendtsen, F. & Christensen, E. Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis. Gut 60, 1254-1259 (2011).
-
(2011)
Gut
, vol.60
, pp. 1254-1259
-
-
Møller, S.1
Hobolth, L.2
Winkler, C.3
Bendtsen, F.4
Christensen, E.5
-
13
-
-
0027973463
-
Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis
-
Follo, A. et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis. Hepatology 20, 1495-1501 (1994).
-
(1994)
Hepatology
, vol.20
, pp. 1495-1501
-
-
Follo, A.1
-
14
-
-
33846433657
-
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features
-
Fasolato, S. et al. Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features. Hepatology 45, 223-229 (2007).
-
(2007)
Hepatology
, vol.45
, pp. 223-229
-
-
Fasolato, S.1
-
15
-
-
0026755224
-
Endotoxin levels in cirrhotic rats with sterile and infected ascites
-
Sugano, S. Endotoxin levels in cirrhotic rats with sterile and infected ascites. Gastroenterol. Jpn 27, 348-353 (1992).
-
(1992)
Gastroenterol. Jpn
, vol.27
, pp. 348-353
-
-
Sugano, S.1
-
16
-
-
0033836743
-
Effects of lipopolysaccharide on TNF a production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis
-
Heller, J. et al. Effects of lipopolysaccharide on TNF a production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J. Hepatol. 33, 376-381 (2000).
-
(2000)
J. Hepatol.
, vol.33
, pp. 376-381
-
-
Heller, J.1
-
17
-
-
0032696338
-
Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility
-
Wiest, R. et al. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J. Clin. Invest. 104, 1223-1233 (1999).
-
(1999)
J. Clin. Invest.
, vol.104
, pp. 1223-1233
-
-
Wiest, R.1
-
18
-
-
0037219393
-
Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement
-
Albillos, A. et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 37, 208-217 (2003).
-
(2003)
Hepatology
, vol.37
, pp. 208-217
-
-
Albillos, A.1
-
19
-
-
22344434535
-
Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: Role of Akt signaling
-
Tazi, K. A. et al. Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: Role of Akt signaling. Gastroenterology 129, 303-314 (2005).
-
(2005)
Gastroenterology
, vol.129
, pp. 303-314
-
-
Tazi, K.A.1
-
20
-
-
0034872638
-
Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis
-
Cejudo-Martín, P. et al. Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 34, 487-493 (2001).
-
(2001)
Hepatology
, vol.34
, pp. 487-493
-
-
Cejudo-Martín, P.1
-
21
-
-
36348935694
-
Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats
-
Fernandez, M. et al. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology 46, 1208-1217 (2007).
-
(2007)
Hepatology
, vol.46
, pp. 1208-1217
-
-
Fernandez, M.1
-
22
-
-
77955853856
-
Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension
-
Bosch, J., Abraldes, J. G., Fernández, M. & García-Pagán, J. C. Hepatic endothelial dysfunction and abnormal angiogenesis: New targets in the treatment of portal hypertension. J. Hepatol. 53, 558-567 (2010).
-
(2010)
J. Hepatol.
, vol.53
, pp. 558-567
-
-
Bosch, J.1
Abraldes, J.G.2
Fernández, M.3
García-Pagán, J.C.4
-
23
-
-
59749085643
-
Cirrhotic cardiomyopathy
-
Wong, F. Cirrhotic cardiomyopathy. Hepatol. Int. 3, 294-304 (2009).
-
(2009)
Hepatol. Int.
, vol.3
, pp. 294-304
-
-
Wong, F.1
-
24
-
-
23044508419
-
Circulatory function and hepatorenal syndrome in cirrhosis
-
Ruiz del Arbol, L. et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 42, 439-447 (2005).
-
(2005)
Hepatology
, vol.42
, pp. 439-447
-
-
Ruiz Del Arbol, L.1
-
25
-
-
73449112667
-
Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites
-
Krag, A., Bendtsen, F., Henriksen, J. H. & Møller, S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut 59, 105-110 (2010).
-
(2010)
Gut
, vol.59
, pp. 105-110
-
-
Krag, A.1
Bendtsen, F.2
Henriksen, J.H.3
Møller, S.4
-
26
-
-
0142244899
-
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis
-
Ruiz del Arbol, L. et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 38, 1210-1218 (2003).
-
(2003)
Hepatology
, vol.38
, pp. 1210-1218
-
-
Ruiz Del Arbol, L.1
-
27
-
-
37349124906
-
Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis
-
Stadlbauer, V. et al. Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis. Gastroenterology 134, 111-119 (2008).
-
(2008)
Gastroenterology
, vol.134
, pp. 111-119
-
-
Stadlbauer, V.1
-
28
-
-
81355138638
-
Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice
-
Salerno, F. et al. Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice. J. Hepatol. 55, 1241-1248 (2011).
-
(2011)
J. Hepatol.
, vol.55
, pp. 1241-1248
-
-
Salerno, F.1
-
29
-
-
0020395710
-
Acute tubular necrosis in hepatorenal syndrome: An electron microscopy study
-
Mandal, A. K., Lansing, M. & Fahmy, A. Acute tubular necrosis in hepatorenal syndrome: An electron microscopy study. Am. J. Kidney Dis. 2, 363-374 (1982).
-
(1982)
Am. J. Kidney Dis.
, vol.2
, pp. 363-374
-
-
Mandal, A.K.1
Lansing, M.2
Fahmy, A.3
-
30
-
-
77954379963
-
The spectrum of renal lesions in patients with cirrhosis: A clinicopathological study
-
Trawalé, J. M. et al. The spectrum of renal lesions in patients with cirrhosis: A clinicopathological study. Liver Int. 30, 725-732 (2010).
-
(2010)
Liver Int.
, vol.30
, pp. 725-732
-
-
Trawalé, J.M.1
-
32
-
-
0020060933
-
Aminoglycoside nephrotoxicity in cirrhosis value of urinary β2-microglobulin to discriminate functional renal failure from acute tubular damage
-
Cabrera, J. et al. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary β2-microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology 82, 97-105 (1982).
-
(1982)
Gastroenterology
, vol.82
, pp. 97-105
-
-
Cabrera, J.1
-
33
-
-
0031863011
-
Ischemic renal diseases: New insights into old entities
-
Meyrier, A., Hill, G. S. & Simon, P. Ischemic renal diseases: New insights into old entities. Kidney Int. 54, 2-13 (1998).
-
(1998)
Kidney Int.
, vol.54
, pp. 2-13
-
-
Meyrier, A.1
Hill, G.S.2
Simon, P.3
-
34
-
-
42949122561
-
Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites
-
Sersté, T., Lebrec, D., Valla, D. & Moreau, R. Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites. Acta Gastroenterol. Belg. 71, 9-14 (2008).
-
(2008)
Acta Gastroenterol. Belg.
, vol.71
, pp. 9-14
-
-
Sersté, T.1
Lebrec, D.2
Valla, D.3
Moreau, R.4
-
35
-
-
79953093468
-
Acute on chronic liver failure: From concept to a new syndrome
-
Jalan, R. Acute on chronic liver failure: From concept to a new syndrome. Curr. Opin. Crit. Care 17, 152 (2011).
-
(2011)
Curr. Opin. Crit. Care
, vol.17
, pp. 152
-
-
Jalan, R.1
-
36
-
-
79953116158
-
Acute on chronic liver failure: Concept, natural history, and prognosis
-
Olsen, J. C. & Kamath, P. S. Acute on chronic liver failure: Concept, natural history, and prognosis. Curr. Opin. Crit. Care 17, 165-169 (2011).
-
(2011)
Curr. Opin. Crit. Care
, vol.17
, pp. 165-169
-
-
Olsen, J.C.1
Kamath, P.S.2
-
37
-
-
73149110852
-
Severe sepsis in cirrhosis
-
Gustot, T., Durand, F., Lebrec, D., Vincent, J. L. & Moreau, R. Severe sepsis in cirrhosis. Hepatology 50, 2022-2033 (2009).
-
(2009)
Hepatology
, vol.50
, pp. 2022-2033
-
-
Gustot, T.1
Durand, F.2
Lebrec, D.3
Vincent, J.L.4
Moreau, R.5
-
38
-
-
40149103666
-
Pathogenesis and treatment of hepatorenal syndrome
-
Arroyo, V., Fernandez, J. & Ginès, P. Pathogenesis and treatment of hepatorenal syndrome. Semin. Liver Dis. 28, 81-95 (2008).
-
(2008)
Semin. Liver Dis.
, vol.28
, pp. 81-95
-
-
Arroyo, V.1
Fernandez, J.2
Ginès, P.3
-
39
-
-
84863484199
-
Is type 1 hepatorenal syndrome reversible after liver transplantation? [abstract 653
-
Leung, W., Al Beshir, M., Marquez, M., Renner, E. & Wong, F. Is type 1 hepatorenal syndrome reversible after liver transplantation? [abstract 653]. J. Hepatol. 56 (Suppl. 2), S258-S259 (2012).
-
(2012)
J. Hepatol.
, vol.56
, Issue.SUPPL. 2
-
-
Leung, W.1
Al Beshir, M.2
Marquez, M.3
Renner, E.4
Wong, F.5
-
40
-
-
59849122428
-
Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: A retrospective study
-
Terg, R. et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: A retrospective study. Liver Int. 29, 415-419 (2009).
-
(2009)
Liver Int.
, vol.29
, pp. 415-419
-
-
Terg, R.1
-
41
-
-
34147202689
-
Restricted use of albumin for spontaneous bacterial peritonitis
-
Sigal, S. H., Stanca, C. M., Fernández, J., Arroyo, V. & Navasa, M. Restricted use of albumin for spontaneous bacterial peritonitis. Gut 56, 597-599 (2007).
-
(2007)
Gut
, vol.56
, pp. 597-599
-
-
Sigal, S.H.1
Stanca, C.M.2
Fernández, J.3
Arroyo, V.4
Navasa, M.5
-
42
-
-
84857192662
-
Role of albumin in the treatment in patients with spontaneous bacterial peritonitis
-
Poca, M. et al. Role of albumin in the treatment in patients with spontaneous bacterial peritonitis. Clin. Gastroenterol. Hepatol. 10, 309-315 (2012).
-
(2012)
Clin. Gastroenterol. Hepatol.
, vol.10
, pp. 309-315
-
-
Poca, M.1
-
43
-
-
0033527033
-
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis
-
Sort, P. et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N. Engl. J. Med. 341, 403-409 (1999).
-
(1999)
N. Engl. J. Med.
, vol.341
, pp. 403-409
-
-
Sort, P.1
-
44
-
-
79961209982
-
Meta-Analysis: Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding-An updated Cochrane review
-
Chavez-Tapia, N. C. et al. Meta-Analysis: Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding-An updated Cochrane review. Aliment. Pharmacol. Ther. 34, 509-518 (2011).
-
(2011)
Aliment. Pharmacol. Ther.
, vol.34
, pp. 509-518
-
-
Chavez-Tapia, N.C.1
-
45
-
-
61549143389
-
Pharmacology clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome
-
Saner, F. H., Canbay, A., Gerken, G. & Broelsch, C. E. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome. Expert Rev. Gastroenterol. Hepatol. 1, 207-217 (2007).
-
(2007)
Expert Rev. Gastroenterol. Hepatol.
, vol.1
, pp. 207-217
-
-
Saner, F.H.1
Canbay, A.2
Gerken, G.3
Broelsch, C.E.4
-
46
-
-
0025007486
-
A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices
-
Chiu, K. W., Sheen, I. S. & Liaw, Y. F. A controlled study of glypressin versus vasopressin in the control of bleeding from oesophageal varices. J. Gastroenterol. Hepatol. 5, 549-553 (1990).
-
(1990)
J. Gastroenterol. Hepatol.
, vol.5
, pp. 549-553
-
-
Chiu, K.W.1
Sheen, I.S.2
Liaw, Y.F.3
-
47
-
-
42949104076
-
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome
-
Sanyal, A. J. et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134, 1360-1368 (2008).
-
(2008)
Gastroenterology
, vol.134
, pp. 1360-1368
-
-
Sanyal, A.J.1
-
48
-
-
42949160648
-
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: A randomized study
-
Martín-Llahí, M. et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: A randomized study. Gastroenterology 134, 1352-1359 (2008).
-
(2008)
Gastroenterology
, vol.134
, pp. 1352-1359
-
-
Martín-Llahí, M.1
-
49
-
-
79960450415
-
Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics
-
Boyer, T. D. et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: Relationship of serum creatinine to hemodynamics. J. Hepatol. 55, 315-321 (2011).
-
(2011)
J. Hepatol.
, vol.55
, pp. 315-321
-
-
Boyer, T.D.1
-
50
-
-
73449116381
-
Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome
-
Nazar, A. et al. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 51, 219-226 (2010).
-
(2010)
Hepatology
, vol.51
, pp. 219-226
-
-
Nazar, A.1
-
51
-
-
33846074784
-
Drug insight: The role of albumin in the management of chronic liver disease
-
Wong, F. Drug insight: The role of albumin in the management of chronic liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 4, 43-51 (2007).
-
(2007)
Nat. Clin. Pract. Gastroenterol. Hepatol.
, vol.4
, pp. 43-51
-
-
Wong, F.1
-
52
-
-
0025641286
-
Pharmacokinetics of terlipressin after single iv doses to healthy volunteers
-
Nilsson, G., Lindblom, P., Ohlin, M., Berling, R. & Vernersson, E. Pharmacokinetics of terlipressin after single i.v. doses to healthy volunteers. Drugs Exp. Clin. Res. 16, 307-314 (1990).
-
(1990)
Drugs Exp. Clin. Res.
, vol.16
, pp. 307-314
-
-
Nilsson, G.1
Lindblom, P.2
Ohlin, M.3
Berling, R.4
Vernersson, E.5
-
53
-
-
84872213242
-
Terlipressin given as continuous intravenous infusion is the more suitable schedule for the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis: Results of a controlled clinical trial [abstract LB3]
-
Angeli, P. et al. Terlipressin given as continuous intravenous infusion is the more suitable schedule for the treatment of type 1 hepatorenal syndrome (HRS) in patients with cirrhosis: Results of a controlled clinical trial [abstract LB3]. Hepatology 48 (Suppl.), 378A (2008).
-
(2008)
Hepatology
, vol.48 A378
, Issue.SUPPL.
-
-
Angeli, P.1
-
54
-
-
69249141116
-
Terlipressin for hepatorenal syndrome: Continuous infusion as an alternative to iv bolus administration
-
Gerbes, A. L., Huber, E. & Gülberg, V. Terlipressin for hepatorenal syndrome: Continuous infusion as an alternative to i.v. bolus administration. Gastroenterology 137, 1179-1181 (2009).
-
(2009)
Gastroenterology
, vol.137
, pp. 1179-1181
-
-
Gerbes, A.L.1
Huber, E.2
Gülberg, V.3
-
55
-
-
0031058016
-
Time profile of the haemodynamic effects of terlipressin in portal hypertension
-
Escorsell, A. et al. Time profile of the haemodynamic effects of terlipressin in portal hypertension. J. Hepatol. 26, 621-627 (1997).
-
(1997)
J. Hepatol.
, vol.26
, pp. 621-627
-
-
Escorsell, A.1
-
56
-
-
79960469956
-
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation
-
Piano, S. et al. Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation? J. Hepatol. 55, 491-496 (2011).
-
(2011)
J. Hepatol.
, vol.55
, pp. 491-496
-
-
Piano, S.1
-
57
-
-
0033065188
-
Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide
-
Angeli, P. et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 29, 1690-1697 (1999).
-
(1999)
Hepatology
, vol.29
, pp. 1690-1697
-
-
Angeli, P.1
-
58
-
-
3042696433
-
Midodrine octreotide, albumin and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome
-
Wong, F., Pantea, L. & Sniderman, K. Midodrine, octreotide, albumin and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology 40, 55-64 (2004).
-
(2004)
Hepatology
, vol.40
, pp. 55-64
-
-
Wong, F.1
Pantea, L.2
Sniderman, K.3
-
59
-
-
33847179154
-
Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome
-
Esrailian, E., Pantangco, E. R., Kyulo, N. L., Hu, K. Q. & Runyon, B. A. Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig. Dis. Sci. 52, 742-748 (2007).
-
(2007)
Dig. Dis. Sci.
, vol.52
, pp. 742-748
-
-
Esrailian, E.1
Pantangco, E.R.2
Kyulo, N.L.3
Hu, K.Q.4
Runyon, B.A.5
-
60
-
-
84872205818
-
Terlipressin and albumin vs. midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: Results of a controlled clinical trial by the Italian Association for the Study of the Liver [abstract LB 2
-
Cavallin, M. et al. Terlipressin and albumin vs. midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: Results of a controlled clinical trial by the Italian Association for the Study of the Liver [abstract LB 2]. Hepatology 54 (Suppl. 1), 1426A (2011).
-
(2011)
Hepatology
, vol.54
, Issue.SUPPL. 1
-
-
Cavallin, M.1
-
61
-
-
79955627076
-
Liver transplant outcomes for patients with hepatorenal syndrome treated with pretransplant vasoconstrictors and albumin
-
Rice, J. P., Skagen, C. & Said, A. Liver transplant outcomes for patients with hepatorenal syndrome treated with pretransplant vasoconstrictors and albumin. Transplantation 91, 1141-1147 (2011).
-
(2011)
Transplantation
, vol.91
, pp. 1141-1147
-
-
Rice, J.P.1
Skagen, C.2
Said, A.3
-
62
-
-
50649122545
-
An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response
-
Sharma, P., Kumar, A., Shrama, B. C. & Sarin, S. K. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am. J. Gastroenterol. 103, 1689-1697 (2008).
-
(2008)
Am. J. Gastroenterol.
, vol.103
, pp. 1689-1697
-
-
Sharma, P.1
Kumar, A.2
Shrama, B.C.3
Sarin, S.K.4
-
63
-
-
34548266811
-
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study
-
Alessandria, C. et al. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study. J. Hepatol. 47, 499-505 (2007).
-
(2007)
J. Hepatol.
, vol.47
, pp. 499-505
-
-
Alessandria, C.1
-
64
-
-
84863393358
-
Noradrenaline versus terlipressin in the treatment of hepatorenal syndrome: A randomized study
-
Singh, V. et al. Noradrenaline versus terlipressin in the treatment of hepatorenal syndrome: A randomized study. J. Hepatol. http://dx.doi.org/10.1016/ j.jhep.2012.01.012.
-
J. Hepatol.
-
-
Singh, V.1
-
65
-
-
75449112998
-
Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
-
Gluud, L. L., Christensen, K., Christensen, E. & Krag, A. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome. Hepatology 51, 576-584 (2010).
-
(2010)
Hepatology
, vol.51
, pp. 576-584
-
-
Gluud, L.L.1
Christensen, K.2
Christensen, E.3
Krag, A.4
-
66
-
-
77951757909
-
Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta-Analysis of randomized controlled trials
-
Sagi, S. V., Mittal, S., Kasturi, K. S. & Sood, G. K. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: A meta-Analysis of randomized controlled trials. J. Gastroenterol. Hepatol. 25, 880-885 (2010).
-
(2010)
J. Gastroenterol. Hepatol.
, vol.25
, pp. 880-885
-
-
Sagi, S.V.1
Mittal, S.2
Kasturi, K.S.3
Sood, G.K.4
-
67
-
-
0042429572
-
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems
-
Guevara, M. et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems. Hepatology 28, 416-422 (1998).
-
(1998)
Hepatology
, vol.28
, pp. 416-422
-
-
Guevara, M.1
-
68
-
-
0031035980
-
Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome
-
Brensing, K. A. et al. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet 349, 697-698 (1997).
-
(1997)
Lancet
, vol.349
, pp. 697-698
-
-
Brensing, K.A.1
-
69
-
-
0033931614
-
Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study
-
Brensing, K. A. et al. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: A phase II study. Gut 47, 288-295 (2000).
-
(2000)
Gut
, vol.47
, pp. 288-295
-
-
Brensing, K.A.1
-
70
-
-
0037230428
-
Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis
-
Jalan, R. et al. Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J. Hepatol. 38, 24-31 (2003).
-
(2003)
J. Hepatol.
, vol.38
, pp. 24-31
-
-
Jalan, R.1
-
71
-
-
25144450974
-
Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure
-
Di Campli, C. et al. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure. Transplant. Proc. 37, 2547-2550 (2005).
-
(2005)
Transplant. Proc.
, vol.37
, pp. 2547-2550
-
-
Di Campli, C.1
-
72
-
-
0034109694
-
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial
-
Mitzner, S. R. et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl. 6, 277-286 (2000).
-
(2000)
Liver Transpl.
, vol.6
, pp. 277-286
-
-
Mitzner, S.R.1
-
73
-
-
77749318513
-
Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment
-
Wong, F., Raina, N. & Richardson, R. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment. Gut 59, 381-386 (2010).
-
(2010)
Gut
, vol.59
, pp. 381-386
-
-
Wong, F.1
Raina, N.2
Richardson, R.3
-
74
-
-
0030877447
-
Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis
-
Ruiz del Arbol, L. et al. Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 113, 579-586 (1997).
-
(1997)
Gastroenterology
, vol.113
, pp. 579-586
-
-
Ruiz del Arbol, L.1
-
75
-
-
0036787604
-
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study
-
Ortega, R. et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study. Hepatology 36, 941-948 (2002).
-
(2002)
Hepatology
, vol.36
, pp. 941-948
-
-
Ortega, R.1
-
76
-
-
0344099365
-
Type 2 hepatorenal syndrome and refractory ascites: Role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation
-
Testino, G. et al. Type 2 hepatorenal syndrome and refractory ascites: Role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. Hepatogastroenterology 50, 1753-1755 (2003).
-
(2003)
Hepatogastroenterology
, vol.50
, pp. 1753-1755
-
-
Testino, G.1
-
77
-
-
0036932433
-
Renal failure in cirrhotic patients: Role of terlipressin in clinical approach to hepatorenal syndrome type 2
-
Alessandria, C., Venon, W. & Marzano, A. Renal failure in cirrhotic patients: Role of terlipressin in clinical approach to hepatorenal syndrome type 2. Eur. J. Gastroenterol. Hepatol. 14, 1363-1368 (2002).
-
(2002)
Eur. J. Gastroenterol. Hepatol.
, vol.14
, pp. 1363-1368
-
-
Alessandria, C.1
Venon, W.2
Marzano, A.3
-
78
-
-
0344951290
-
Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis
-
Cassinello, C. et al. Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig. Dis. Sci. 48, 179-186 (2003).
-
(2003)
Dig. Dis. Sci.
, vol.48
, pp. 179-186
-
-
Cassinello, C.1
-
79
-
-
0037223652
-
Model for end-stage liver disease (MELD) and allocation of donor livers
-
Wiesner, R. et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124, 91-96 (2003).
-
(2003)
Gastroenterology
, vol.124
, pp. 91-96
-
-
Wiesner, R.1
-
80
-
-
85027940113
-
Impact of hepatorenal syndrome and liver transplantation
-
Memon, I. & Klein, C. L. Impact of hepatorenal syndrome and liver transplantation. Curr. Opin. Organ. Transplant. 16, 301-305 (2011).
-
(2011)
Curr. Opin. Organ. Transplant.
, vol.16
, pp. 301-305
-
-
Memon, I.1
Klein, C.L.2
-
81
-
-
0348103707
-
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome A case-control study
-
Restuccia, T. et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J. Hepatol. 40, 140-146 (2004).
-
(2004)
J. Hepatol.
, vol.40
, pp. 140-146
-
-
Restuccia, T.1
-
82
-
-
82955161556
-
Hepatorenal syndrome, pharmacological therapy, and liver transplantation
-
Ginès, P. Hepatorenal syndrome, pharmacological therapy, and liver transplantation. Liver Transpl. 17, 1244-1246 (2011).
-
(2011)
Liver Transpl.
, vol.17
, pp. 1244-1246
-
-
Ginès, P.1
-
83
-
-
24944502810
-
Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy
-
Wong, L. P. et al. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int. 68, 362-370 (2005).
-
(2005)
Kidney Int.
, vol.68
, pp. 362-370
-
-
Wong, L.P.1
-
84
-
-
31544469480
-
The course of type 1 hepatorenal syndrome post liver transplantation
-
Marik, P. E., Wood, K. & Starzl, T. E. The course of type 1 hepatorenal syndrome post liver transplantation. Nephrol. Dial. Transplant. 21, 478-482 (2006).
-
(2006)
Nephrol. Dial. Transplant.
, vol.21
, pp. 478-482
-
-
Marik, P.E.1
Wood, K.2
Starzl, T.E.3
-
85
-
-
0027450547
-
Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients
-
Hadengue, A. et al. Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology 17, 175-178 (1993).
-
(1993)
Hepatology
, vol.17
, pp. 175-178
-
-
Hadengue, A.1
-
86
-
-
34249086997
-
Simultaneous liver-kidney transplantation: Evaluation to decision making
-
Davis, C. L. et al. Simultaneous liver-kidney transplantation: Evaluation to decision making. Am. J. Transplant. 7, 1702-1709 (2007).
-
(2007)
Am. J. Transplant.
, vol.7
, pp. 1702-1709
-
-
Davis, C.L.1
-
87
-
-
77953287182
-
Combined liver and kidney transplantation
-
Papafragkakis, H., Martin, P. & Akalin, E. Combined liver and kidney transplantation. Curr. Opin. Organ. Transplant. 15, 263-268 (2010).
-
(2010)
Curr. Opin. Organ. Transplant.
, vol.15
, pp. 263-268
-
-
Papafragkakis, H.1
Martin, P.2
Akalin, E.3
-
88
-
-
42149182370
-
Declining outcomes in simultaneous liver-kidney transplantation in the meld era: Ineffective usage of renal allografts
-
Locke, J. E. et al. Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: Ineffective usage of renal allografts. Transplantation 85, 935-942 (2008).
-
(2008)
Transplantation
, vol.85
, pp. 935-942
-
-
Locke, J.E.1
-
89
-
-
34250172894
-
Hepatorenal syndrome: A proposal for kidney after liver transplantation (KALT)
-
Ruiz, R. et al. Hepatorenal syndrome: A proposal for kidney after liver transplantation (KALT). Liver Transpl. 13, 838-843 (2007).
-
(2007)
Liver Transpl.
, vol.13
, pp. 838-843
-
-
Ruiz, R.1
-
90
-
-
69949186234
-
Ascites improves upon serum sodium plus model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease
-
Somsouk, M. et al. Ascites improves upon serum sodium plus model for end-stage liver disease (MELD) for predicting mortality in patients with advanced liver disease. Aliment. Pharmacol. Ther. 30, 741-748 (2009).
-
(2009)
Aliment. Pharmacol. Ther.
, vol.30
, pp. 741-748
-
-
Somsouk, M.1
-
91
-
-
79551470420
-
Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk
-
Somsouk, M., Kornfield, R., Vittinghoff, E., Inadomi, J. M. & Biggins, S. W. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Liver Transpl. 17, 129-136 (2011).
-
(2011)
Liver Transpl.
, vol.17
, pp. 129-136
-
-
Somsouk, M.1
Kornfield, R.2
Vittinghoff, E.3
Inadomi, J.M.4
Biggins, S.W.5
-
92
-
-
34548487937
-
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis
-
Fernández, J. et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology 133, 818-824 (2007).
-
(2007)
Gastroenterology
, vol.133
, pp. 818-824
-
-
Fernández, J.1
-
93
-
-
77951792200
-
Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis
-
Lebrec, D. et al. Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis. Gastroenterology 138, 1755-1762 (2010).
-
(2010)
Gastroenterology
, vol.138
, pp. 1755-1762
-
-
Lebrec, D.1
-
94
-
-
0034465251
-
Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
-
Akriviadis, E. et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial. Gastroenterology 119, 1637-1648 (2000).
-
(2000)
Gastroenterology
, vol.119
, pp. 1637-1648
-
-
Akriviadis, E.1
-
95
-
-
75349083359
-
Pentoxifylline for alcoholic hepatitis
-
Art. No.
-
Whitfield, K., Rambaldi, A., Wetterslev, J. & Gluud, C. Pentoxifylline for alcoholic hepatitis. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD007339. http://dx.doi.org/10.1002/14651858.CD007339.pub2.
-
Cochrane Database of Systematic Reviews
, vol.4
-
-
Whitfield, K.1
Rambaldi, A.2
Wetterslev, J.3
Gluud, C.4
-
96
-
-
0027252834
-
Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency
-
Lake, J. R. et al. Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency. Transplant. Proc. 25, 1766-1767 (1993).
-
(1993)
Transplant. Proc.
, vol.25
, pp. 1766-1767
-
-
Lake, J.R.1
-
97
-
-
0029010937
-
Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt
-
Spahr, L. et al. Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt. Am. J. Gastroenterol. 90, 1169-1171 (1995).
-
(1995)
Am. J. Gastroenterol.
, vol.90
, pp. 1169-1171
-
-
Spahr, L.1
|